(Q46764122)

25 December 2017

title

Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation (English)

1 reference

25 December 2017

main subject

Cytomegalovirus

0 references

kidney transplantation

1 reference

Supha K Arthurs

1

1 reference

25 December 2017

Albert J Eid

2

1 reference

25 December 2017

Rachel A Pedersen

3

1 reference

25 December 2017

Walter K Kremers

4

1 reference

25 December 2017

Fernando G Cosio

5

1 reference

25 December 2017

Robin Patel

6

1 reference

25 December 2017

Raymund R Razonable

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

25 December 2017

Clinical Infectious Diseases

published in

1 reference

25 December 2017

volume

46

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

840-846

1 reference

25 December 2017

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

cites work

1 reference

The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection

21 January 2018

1 reference

The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis

21 January 2018

1 reference

Cytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A Review

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

21 January 2018

1 reference

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

21 January 2018

1 reference

Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching

21 January 2018

1 reference

Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients

21 January 2018

1 reference

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models

21 January 2018

1 reference

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

21 January 2018

1 reference

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

High incidence of active cytomegalovirus infection among septic patients

21 January 2018

1 reference

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts

21 January 2018

1 reference

Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice

21 January 2018

1 reference

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/528718

1 reference

25 December 2017

PubMed ID

18260785

1 reference

25 December 2017